A

Forkhead box versus NF-κB hippocampal snRNA-seq profiles distinguish anti-Drebrin- and anti-GAD65-positive encephalitis

Figshare

Abstract

Abstract Background and objectives Autoantibodies (ABs) against intracellular proteins, including glutamate-decarboxylase 65 (anti-GAD65), are increasingly recognized in autoimmune and limbic encephalitis (AE/LE). Anti-GAD65 LE frequently progresses to severe temporal lobe epilepsy (TLE), neuropathologically characterized by hippocampal sclerosis (HS) and variable infiltration of cytotoxic T lymphocytes (CTLs). Recently, we have identified Drebrin (DBN) as a new intracellular target protein of ABs in index patients with suspected AE. Here, we aim to characterize key molecular and cellular signatures of hippocampal tissue from anti-GAD65- (GAD65-TLE) versus anti-DBN-positive TLE (DBN-TLE) patients correlated to clinical parameters. Methods We examined hippocampal neuropathology and performed exploratory single-nucleus RNA sequencing (snRNA-seq) of hippocampal tissue from DBN- and GAD65-TLE patients, integrated with key clinical data from a large patient cohort. Results Although the hippocampi of the two patient groups were neuropathologically virtually indistinguishable, exploratory snRNA-seq revealed distinct transcriptional programs. DBN-TLE patients (n = 2) showed transcriptional signatures enriched for forkhead box (Fox) transcription factor family, whereas GAD65-TLE patients (n = 2) displayed transcriptional signatures enriched for transcripts related to NF-κB- signaling. In a larger cohort, DBN-TLE patients (n = 22) showed significantly more favorable pharmacological responsiveness than GAD65-TLE patients (n = 35), who were largely pharmacoresistant. Notably, in a T cell-mediated mouse model for LE, similar inflammatory programs were dynamically regulated. Conclusion These findings provide a discovery-based transcriptomic signatures of rare autoimmune hippocampal tissue, revealing distinct immune-associated transcriptional states in anti-DBN- versus anti-GAD65-positive AE/TLE patients despite virtually indistinguishable hippocampal pathology in both groups and support further investigations of disease-specific therapeutic strategies.

Authors 17

  1. RWTH Aachen University

    Affiliation as printed

    RWTH Aachen University

  2. University Hospital Bonn

    Affiliation as printed

    University Hospital Bonn

  3. University Hospital Bonn

    Affiliation as printed

    University Hospital Bonn

  4. University Hospital Bonn

    Affiliation as printed

    University Hospital Bonn

  5. University Hospital Bonn

    Affiliation as printed

    University Hospital Bonn

  6. University Hospital Bonn

    Affiliation as printed

    University Hospital Bonn

  7. University Hospital Bonn

    Affiliation as printed

    University Hospital Bonn

  8. Medical University of Vienna

    Affiliation as printed

    Medical University of Vienna

  9. University Hospital Bonn

    Affiliation as printed

    University Hospital Bonn

  10. University Hospital Bonn

    Affiliation as printed

    University Hospital Bonn

  11. University Hospital Bonn

    Affiliation as printed

    University Hospital Bonn

  12. University Hospital Bonn

    Affiliation as printed

    University Hospital Bonn

  13. University Hospital Bonn

    Affiliation as printed

    University Hospital Bonn

  14. University Hospital Bonn

    Affiliation as printed

    University Hospital Bonn

  15. University Hospital Bonn

    Affiliation as printed

    University Hospital Bonn

  16. University Hospital Bonn

    Affiliation as printed

    University Hospital Bonn

Cited by 0 stored of 0

No patents citing this paper on Lens.org (checked 2026-10-06).

References 0